Matthew G. Chaimowitz

853 total citations
19 papers, 308 citations indexed

About

Matthew G. Chaimowitz is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Matthew G. Chaimowitz has authored 19 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Immunology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Matthew G. Chaimowitz's work include Cancer Immunotherapy and Biomarkers (13 papers), Immunotherapy and Immune Responses (7 papers) and Immune cells in cancer (5 papers). Matthew G. Chaimowitz is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Immunotherapy and Immune Responses (7 papers) and Immune cells in cancer (5 papers). Matthew G. Chaimowitz collaborates with scholars based in United States, United Kingdom and Thailand. Matthew G. Chaimowitz's co-authors include Charles G. Drake, Aleksandar Obradović, Wendy Mao, Ali Ghasemzadeh, Zoila A. Lopez‐Bujanda, Nivedita Chowdhury, Casey R. Ager, Jessica E. Hawley, Catherine S. Spina and Matthew C. Dallos and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Matthew G. Chaimowitz

19 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew G. Chaimowitz United States 8 173 155 107 91 34 19 308
Weiyuan Fang China 7 139 0.8× 120 0.8× 97 0.9× 55 0.6× 31 0.9× 14 295
Ryota Sumitomo Japan 9 135 0.8× 166 1.1× 94 0.9× 81 0.9× 41 1.2× 22 317
Loïck Galland France 11 181 1.0× 48 0.3× 61 0.6× 80 0.9× 42 1.2× 25 298
Christophe Van Berckelaer Belgium 11 214 1.2× 86 0.6× 100 0.9× 61 0.7× 122 3.6× 22 350
Alexandra von Au Germany 8 172 1.0× 73 0.5× 49 0.5× 73 0.8× 69 2.0× 27 271
Vinson Wang United States 5 118 0.7× 142 0.9× 158 1.5× 85 0.9× 63 1.9× 7 326
Eriseld Krasniqi Italy 10 197 1.1× 59 0.4× 93 0.9× 95 1.0× 99 2.9× 21 342
Masashi Kitazawa Japan 9 157 0.9× 108 0.7× 96 0.9× 44 0.5× 55 1.6× 12 341
Yasuyuki Kanke Japan 10 141 0.8× 75 0.5× 124 1.2× 78 0.9× 56 1.6× 24 288
Konstantinos Rounis Greece 11 228 1.3× 42 0.3× 82 0.8× 100 1.1× 75 2.2× 24 341

Countries citing papers authored by Matthew G. Chaimowitz

Since Specialization
Citations

This map shows the geographic impact of Matthew G. Chaimowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew G. Chaimowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew G. Chaimowitz more than expected).

Fields of papers citing papers by Matthew G. Chaimowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew G. Chaimowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew G. Chaimowitz. The network helps show where Matthew G. Chaimowitz may publish in the future.

Co-authorship network of co-authors of Matthew G. Chaimowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew G. Chaimowitz. A scholar is included among the top collaborators of Matthew G. Chaimowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew G. Chaimowitz. Matthew G. Chaimowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ager, Casey R., Mingxuan Zhang, Matthew G. Chaimowitz, et al.. (2023). KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response. Journal for ImmunoTherapy of Cancer. 11(9). e006782–e006782. 7 indexed citations
2.
McCann, Patrick J., Wendy Mao, Matthew G. Chaimowitz, et al.. (2023). Abstract B032: Combined A2AR and PARP inhibition in homologous recombination deficient (HRD) castrate-resistant prostate cancer (CRPC). Cancer Research. 83(11_Supplement). B032–B032. 1 indexed citations
3.
Dallos, Matthew C., Samuel Pan, Matthew G. Chaimowitz, et al.. (2022). A randomized phase Ib/II study of intermittent androgen deprivation therapy plus nivolumab with or without interleukin-8 blockade in men with hormone-sensitive prostate cancer (MAGIC-8).. Journal of Clinical Oncology. 40(16_suppl). 5082–5082. 5 indexed citations
4.
Ager, Casey R., Aleksandar Obradović, Juan Martín Arriaga, et al.. (2021). Longitudinal Immune Profiling Reveals Unique Myeloid and T-cell Phenotypes Associated with Spontaneous Immunoediting in a Prostate Tumor Model. Cancer Immunology Research. 9(5). 529–541. 10 indexed citations
5.
Lopez‐Bujanda, Zoila A., Michael C. Haffner, Matthew G. Chaimowitz, et al.. (2021). Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression. Nature Cancer. 2(8). 803–818. 82 indexed citations
6.
Bansal, Swati, Matthew G. Chaimowitz, Casey R. Ager, et al.. (2021). Radiation, Adenosine Signaling, and Immunosuppressive Changes to the Tumor Microenvironment. International Journal of Radiation Oncology*Biology*Physics. 111(3). S88–S89. 1 indexed citations
7.
Hawley, Jessica E., et al.. (2021). Analysis of Circulating Immune Biomarkers by Race in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Sipuleucel-T. JNCI Journal of the National Cancer Institute. 114(2). 314–317. 11 indexed citations
8.
Aggen, David H., Casey R. Ager, Aleksandar Obradović, et al.. (2020). Blocking IL1 Beta Promotes Tumor Regression and Remodeling of the Myeloid Compartment in a Renal Cell Carcinoma Model: Multidimensional Analyses. Clinical Cancer Research. 27(2). 608–621. 92 indexed citations
9.
Spina, Catherine S., Chizuru Tsuruoka, Wendy Mao, et al.. (2020). Differential Immune Modulation With Carbon-Ion Versus Photon Therapy. International Journal of Radiation Oncology*Biology*Physics. 109(3). 813–818. 20 indexed citations
10.
Hawley, Jessica E., Aleksandar Obradović, Xinzheng V. Guo, et al.. (2020). Dissecting the immune infiltrate induced by ADT and PD-1 blockade in men with metastatic hormone-sensitive prostate cancer using single-cell RNA-sequencing.. Journal of Clinical Oncology. 38(15_suppl). e17548–e17548. 1 indexed citations
11.
Dallos, Matthew C., Matthew G. Chaimowitz, Mark N. Stein, et al.. (2020). Effect of androgen deprivation therapy combined with nivolumab on the systemic antitumor immune response in castration-sensitive prostate cancer.. Journal of Clinical Oncology. 38(15_suppl). e17503–e17503. 1 indexed citations
12.
Ager, Casey R., Juan Martín Arriaga, Matthew G. Chaimowitz, et al.. (2020). 497 Longitudinal immune profiling reveals unique myeloid and T cell phenotypes associated with spontaneous immunoediting in a novel prostate tumor model. SHILAP Revista de lepidopterología. A306.1–A306. 1 indexed citations
13.
Lopez‐Bujanda, Zoila A., Matthew G. Chaimowitz, Todd D. Armstrong, et al.. (2020). Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigen. OncoImmunology. 9(1). 1809926–1809926. 5 indexed citations
14.
Mao, Wendy, Ali Ghasemzadeh, Zachary T. Freeman, et al.. (2019). Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition. Journal for ImmunoTherapy of Cancer. 7(1). 277–277. 50 indexed citations
15.
Spina, Catherine S., Zoila A. Lopez‐Bujanda, Wendy Mao, et al.. (2019). Radiation Induces a Dose-Dependent Increase in Immunosuppressive Myeloid Cells in Solid Tumors. International Journal of Radiation Oncology*Biology*Physics. 105(1). S124–S125. 2 indexed citations
16.
Aggen, David H., Ali Ghasemzadeh, Wendy Mao, et al.. (2019). Preclinical development of combination therapy targeting the dominant cytokine interleukin-1β for renal cell carcinoma.. Journal of Clinical Oncology. 37(15_suppl). e14237–e14237. 3 indexed citations
17.
Valera, Vladimir, Derek Prabharasuth, Matthew G. Chaimowitz, et al.. (2017). Is targeting glycolysis with 2-deoxyglucose a viable therapeutic approach to bladder cancer?. 7 indexed citations
18.
Chaimowitz, Matthew G., et al.. (2016). Alternative Therapeutic Approach to Urothelial Cell Carcinoma with Medicinal Mushroom Extracts. 4(5). 73–79. 1 indexed citations
19.
Schulman, Ariel, Matthew G. Chaimowitz, Muhammad Choudhury, Majid Eshghi, & Sensuke Konno. (2016). Antioxidant and Renoprotective Effects of Mushroom Extract: Implication in Prevention of Nephrolithiasis. Journal of Clinical Medicine Research. 8(12). 908–915. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weiyuan Fang Breakdown of academic impact, for papers by Ryota Sumitomo Breakdown of academic impact, for papers by Loïck Galland Breakdown of academic impact, for papers by Christophe Van Berckelaer Breakdown of academic impact, for papers by Alexandra von Au Breakdown of academic impact, for papers by Vinson Wang Breakdown of academic impact, for papers by Eriseld Krasniqi Breakdown of academic impact, for papers by Masashi Kitazawa Breakdown of academic impact, for papers by Yasuyuki Kanke Breakdown of academic impact, for papers by Konstantinos Rounis
Rankless by CCL
2026